| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
37,734 |
33,960 |
$2.48M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
19,327 |
17,590 |
$2.24M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
11,533 |
10,279 |
$1.09M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
24,714 |
22,720 |
$800K |
| 71045 |
Radiologic examination, chest; single view |
14,430 |
12,958 |
$522K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
985 |
916 |
$502K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
20,108 |
17,970 |
$437K |
| 80053 |
Comprehensive metabolic panel |
50,201 |
41,228 |
$333K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,902 |
1,749 |
$321K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,622 |
1,488 |
$312K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,006 |
6,728 |
$264K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
53,186 |
43,894 |
$259K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
557 |
510 |
$223K |
| 80050 |
General health panel |
6,290 |
5,115 |
$217K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
9,837 |
5,420 |
$216K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,221 |
5,493 |
$182K |
| 36415 |
Collection of venous blood by venipuncture |
83,760 |
67,493 |
$164K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,059 |
1,922 |
$144K |
| 43775 |
|
421 |
330 |
$139K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,656 |
3,254 |
$133K |
| 83735 |
|
29,674 |
25,736 |
$131K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,857 |
4,419 |
$103K |
| 84484 |
|
11,279 |
9,853 |
$93K |
| 87400 |
|
10,448 |
4,589 |
$76K |
| 82553 |
|
10,997 |
9,574 |
$76K |
| 81025 |
|
11,343 |
10,181 |
$71K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,218 |
1,107 |
$57K |
| 80061 |
Lipid panel |
5,758 |
5,101 |
$57K |
| 81001 |
|
24,504 |
22,083 |
$54K |
| 43281 |
|
85 |
81 |
$53K |
| 82550 |
|
11,449 |
10,062 |
$50K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,732 |
7,829 |
$48K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
64 |
62 |
$46K |
| 83690 |
|
8,622 |
7,728 |
$42K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,303 |
1,161 |
$37K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,294 |
1,162 |
$37K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,551 |
4,006 |
$31K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
339 |
180 |
$31K |
| G0378 |
Hospital observation service, per hour |
473 |
152 |
$25K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,496 |
6,685 |
$24K |
| 84481 |
|
2,582 |
2,264 |
$22K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,905 |
2,682 |
$22K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
714 |
634 |
$20K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,361 |
659 |
$19K |
| 88307 |
|
360 |
342 |
$16K |
| 84439 |
|
2,496 |
2,170 |
$16K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
261 |
233 |
$16K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
39 |
37 |
$16K |
| 88342 |
|
924 |
877 |
$15K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,023 |
2,770 |
$15K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,227 |
1,098 |
$14K |
| 82728 |
|
1,808 |
1,505 |
$14K |
| 71046 |
Radiologic examination, chest; 2 views |
335 |
243 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
878 |
612 |
$13K |
| 94761 |
|
953 |
270 |
$12K |
| 83550 |
|
2,122 |
1,795 |
$12K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
281 |
108 |
$11K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
212 |
196 |
$11K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
34 |
31 |
$10K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,889 |
3,314 |
$10K |
| 83540 |
|
2,130 |
1,797 |
$9K |
| C1769 |
Guide wire |
115 |
97 |
$8K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
283 |
219 |
$8K |
| 84436 |
|
1,769 |
1,463 |
$8K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
297 |
88 |
$7K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
29 |
26 |
$7K |
| 95811 |
|
13 |
12 |
$7K |
| 58662 |
|
13 |
12 |
$7K |
| 84100 |
|
2,754 |
1,840 |
$7K |
| 83880 |
|
324 |
296 |
$6K |
| 87420 |
|
486 |
420 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
569 |
507 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
123 |
80 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
112 |
108 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,304 |
1,112 |
$4K |
| 86140 |
|
1,237 |
1,081 |
$4K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
97 |
85 |
$4K |
| 73630 |
|
119 |
98 |
$4K |
| 83615 |
|
1,128 |
953 |
$4K |
| 94010 |
|
76 |
75 |
$3K |
| 84479 |
|
827 |
635 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
153 |
121 |
$3K |
| 84480 |
|
369 |
341 |
$3K |
| 86160 |
|
286 |
136 |
$3K |
| 94727 |
|
76 |
75 |
$3K |
| 94729 |
|
76 |
75 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
896 |
796 |
$3K |
| 84153 |
|
170 |
160 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
938 |
630 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
166 |
158 |
$2K |
| J3490 |
Unclassified drugs |
1,440 |
806 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
215 |
196 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,896 |
1,656 |
$2K |
| 87653 |
|
65 |
59 |
$2K |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
626 |
562 |
$2K |
| 81003 |
|
1,347 |
1,039 |
$2K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
113 |
26 |
$2K |
| 71250 |
|
12 |
12 |
$2K |
| 84425 |
|
101 |
83 |
$2K |
| 95819 |
|
14 |
13 |
$1K |
| 82607 |
|
137 |
110 |
$1K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
237 |
205 |
$1K |
| 80076 |
|
243 |
218 |
$1K |
| 82962 |
|
677 |
567 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
67 |
61 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,064 |
1,720 |
$1K |
| 82746 |
|
112 |
84 |
$1K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
12 |
12 |
$1K |
| 72110 |
|
12 |
12 |
$1K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
385 |
357 |
$957.82 |
| 82077 |
|
92 |
80 |
$857.82 |
| 94664 |
|
99 |
90 |
$833.52 |
| 97161 |
|
30 |
29 |
$819.28 |
| 84702 |
|
65 |
58 |
$785.30 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
379 |
313 |
$735.05 |
| 95806 |
|
16 |
13 |
$712.16 |
| 82565 |
|
214 |
195 |
$709.90 |
| J1644 |
Injection, heparin sodium, per 1000 units |
158 |
95 |
$697.35 |
| 76937 |
|
14 |
13 |
$696.68 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
24 |
24 |
$690.15 |
| 87040 |
|
59 |
55 |
$671.73 |
| 74018 |
|
12 |
12 |
$644.96 |
| A6257 |
Transparent film, sterile, 16 sq. in. or less, each dressing |
420 |
386 |
$598.76 |
| J2704 |
Injection, propofol, 10 mg |
2,883 |
2,210 |
$581.51 |
| 86592 |
|
149 |
134 |
$572.24 |
| 83605 |
|
71 |
64 |
$557.11 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
16 |
15 |
$555.91 |
| 85651 |
|
218 |
195 |
$552.42 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
154 |
134 |
$547.14 |
| 87186 |
|
100 |
91 |
$537.08 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
32 |
30 |
$433.54 |
| C9113 |
Injection, pantoprazole sodium, per vial |
209 |
131 |
$398.98 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
255 |
151 |
$383.53 |
| 87077 |
|
75 |
67 |
$339.84 |
| 73030 |
|
12 |
12 |
$337.00 |
| 82950 |
|
65 |
65 |
$282.47 |
| 90715 |
|
12 |
12 |
$229.86 |
| 83970 |
|
15 |
12 |
$165.12 |
| 82652 |
|
14 |
14 |
$164.16 |
| 86703 |
|
13 |
12 |
$155.22 |
| 84520 |
|
49 |
46 |
$139.36 |
| 84550 |
|
75 |
70 |
$126.84 |
| J7050 |
Infusion, normal saline solution, 250 cc |
81 |
52 |
$103.46 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
17 |
12 |
$100.73 |
| 86850 |
|
13 |
12 |
$74.54 |
| 36000 |
|
32 |
28 |
$64.55 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
246 |
166 |
$61.87 |
| 85379 |
|
13 |
12 |
$61.08 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
12 |
12 |
$57.09 |
| 86900 |
|
13 |
12 |
$33.07 |
| 86901 |
|
13 |
12 |
$33.07 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
60 |
24 |
$30.90 |
| J7510 |
Prednisolone oral, per 5 mg |
16 |
12 |
$23.85 |
| 85610 |
|
14 |
14 |
$9.37 |
| 85730 |
|
12 |
12 |
$7.12 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
13 |
13 |
$6.50 |
| A6402 |
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing |
26 |
24 |
$0.47 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
2,671 |
303 |
$0.00 |
| 02414 |
|
109 |
105 |
$0.00 |
| 72100 |
|
197 |
174 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
15 |
14 |
$0.00 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
39 |
26 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
41 |
38 |
$0.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
28 |
12 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
18 |
16 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
983 |
643 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
104 |
69 |
$0.00 |